Hemodialysis

Rockwell Signs Licensing Agreements to Market Water-Soluble Iron Through Its Dialysate

Published in Blood Weekly, February 7th, 2002

Rockwell Medical Technologies, Inc., has signed separate licensing agreements that give the company exclusive, worldwide proprietary rights to manufacture, market and distribute a water-soluble iron supplement via the company's dialysate.

Rockwell has entered into global licensing agreements, with both Ash Medical Systems, Inc., and Charak, LLC, that grant the company the exclusive, worldwide rights to manufacture, market and distribute liquid and dry dialysate compositions containing water-soluble iron to be administered to both hemodialysis and peritoneal dialysis patients with renal failure.

Ash Medical Systems was cofounded by nephrologist Dr....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-02-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry